Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial.
Tam AR, Zhang RR, Lung KC, Liu R, Leung KY, Liu D, Fan Y, Lu L, Lam AH, Chung TW, Yip CC, Lo J, Wu AK, Lee R, Sin S, Ng PY, Chan WM, Shum HP, Yan WW, Chan JF, Cheng VC, Lau CS, To KK, Chan KH, Yuen KY, Hung IF.
Tam AR, et al. Among authors: chan jf, chan kh, chan wm.
Clin Infect Dis. 2023 Feb 8;76(3):e216-e226. doi: 10.1093/cid/ciac523.
Clin Infect Dis. 2023.
PMID: 35762834
Free PMC article.
Clinical Trial.